Gut bacteria cocktail aims to help ailing livers
NCT ID NCT06871111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing whether giving a mix of healthy gut bacteria (from donors) to people hospitalized with serious liver disease is safe and tolerable. The study involves 24 adults with liver failure or cirrhosis who have low levels of certain gut metabolites. Researchers will monitor side effects and check if the bacteria take hold in the gut.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app tame Alcohol-Related liver disease?
- Can a smarter scan make liver testing more reliable?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Can a quick MRI scan reveal what a healthy Child's liver looks like?
- A machine that keeps donor livers alive outside the body — could it transform transplantation?